EQ
Price
$0.31
Change
-$0.03 (-8.82%)
Updated
Jun 27 closing price
Capitalization
11.07M
37 days until earnings call
PRQR
Price
$2.04
Change
-$0.12 (-5.56%)
Updated
Jun 27 closing price
Capitalization
214.9M
31 days until earnings call
Interact to see
Advertisement

EQ vs PRQR

Header iconEQ vs PRQR Comparison
Open Charts EQ vs PRQRBanner chart's image
Equillium
Price$0.31
Change-$0.03 (-8.82%)
Volume$232.3K
Capitalization11.07M
ProQR Therapeutics
Price$2.04
Change-$0.12 (-5.56%)
Volume$1M
Capitalization214.9M
EQ vs PRQR Comparison Chart in %
Loading...
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EQ vs. PRQR commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQ is a Buy and PRQR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (EQ: $0.34 vs. PRQR: $2.04)
Brand notoriety: EQ and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EQ: 0% vs. PRQR: 221%
Market capitalization -- EQ: $11.07M vs. PRQR: $214.9M
EQ [@Biotechnology] is valued at $11.07M. PRQR’s [@Biotechnology] market capitalization is $214.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EQ’s FA Score shows that 1 FA rating(s) are green whilePRQR’s FA Score has 0 green FA rating(s).

  • EQ’s FA Score: 1 green, 4 red.
  • PRQR’s FA Score: 0 green, 5 red.
According to our system of comparison, PRQR is a better buy in the long-term than EQ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EQ’s TA Score shows that 5 TA indicator(s) are bullish while PRQR’s TA Score has 3 bullish TA indicator(s).

  • EQ’s TA Score: 5 bullish, 2 bearish.
  • PRQR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, EQ is a better buy in the short-term than PRQR.

Price Growth

EQ (@Biotechnology) experienced а +4.16% price change this week, while PRQR (@Biotechnology) price change was +5.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

EQ is expected to report earnings on Aug 06, 2025.

PRQR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRQR($215M) has a higher market cap than EQ($11.1M). PRQR YTD gains are higher at: -23.019 vs. EQ (-54.491). EQ has higher annual earnings (EBITDA): -13.65M vs. PRQR (-26.88M). PRQR has more cash in the bank: 132M vs. EQ (14.5M). EQ has less debt than PRQR: EQ (295K) vs PRQR (16.9M). EQ has higher revenues than PRQR: EQ (30.4M) vs PRQR (19M).
EQPRQREQ / PRQR
Capitalization11.1M215M5%
EBITDA-13.65M-26.88M51%
Gain YTD-54.491-23.019237%
P/E RatioN/AN/A-
Revenue30.4M19M160%
Total Cash14.5M132M11%
Total Debt295K16.9M2%
FUNDAMENTALS RATINGS
EQ vs PRQR: Fundamental Ratings
EQ
PRQR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
8942
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EQ's Valuation (19) in the Biotechnology industry is in the same range as PRQR (34). This means that EQ’s stock grew similarly to PRQR’s over the last 12 months.

EQ's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PRQR (100). This means that EQ’s stock grew similarly to PRQR’s over the last 12 months.

PRQR's SMR Rating (97) in the Biotechnology industry is in the same range as EQ (98). This means that PRQR’s stock grew similarly to EQ’s over the last 12 months.

PRQR's Price Growth Rating (42) in the Biotechnology industry is somewhat better than the same rating for EQ (89). This means that PRQR’s stock grew somewhat faster than EQ’s over the last 12 months.

PRQR's P/E Growth Rating (100) in the Biotechnology industry is in the same range as EQ (100). This means that PRQR’s stock grew similarly to EQ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EQPRQR
RSI
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
83%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 19 days ago
84%
Bullish Trend 19 days ago
85%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 21 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASAZY15.690.38
+2.48%
Assa Abloy AB
TGMGF0.02N/A
N/A
Theta Gold Mines Limited
RPHCF14.72N/A
N/A
Rohto Pharmaceutical Co.
PMDRF0.05N/A
N/A
SONORAN DESERT COPPER CORP
PTNRF6.90N/A
N/A
Partner Communications Company Ltd.

EQ and

Correlation & Price change

A.I.dvisor indicates that over the last year, EQ has been loosely correlated with MIST. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if EQ jumps, then MIST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EQ
1D Price
Change %
EQ100%
N/A
MIST - EQ
45%
Loosely correlated
-1.59%
MTNB - EQ
38%
Loosely correlated
-2.32%
IMNM - EQ
31%
Poorly correlated
-0.23%
PRQR - EQ
25%
Poorly correlated
-5.56%
MURA - EQ
25%
Poorly correlated
N/A
More

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with WVE. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
-5.56%
WVE - PRQR
60%
Loosely correlated
-5.12%
KRRO - PRQR
59%
Loosely correlated
-3.16%
ATNF - PRQR
55%
Loosely correlated
-4.27%
PHMMF - PRQR
36%
Loosely correlated
N/A
VYGR - PRQR
34%
Loosely correlated
-0.34%
More